Roy E. Wuthier
9Patents
4h-index
7Co-inventors
46Inventor score
Filing activity: Nov 21, 1997 → Dec 27, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6808561B2 | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement | Chemistry; Metallurgy | 77 | Expired |
| US7081161B2 | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using cement | Chemistry; Metallurgy | 30 | Expired |
| US7527687B2 | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement | Chemistry; Metallurgy | 14 | Active |
| US5932611A | Angiogenesis inhibitor for the treatment of cancer | Human Necessities | 7 | Expired |
| US6660765B2 | FC101 as a method of treatment for cancer | Human Necessities | 4 | Expired |
| US6225340A | Angiogenesis inhibitor for the treatment of endothelial cell proliferation | Human Necessities | 4 | Expired |
| US7078433B2 | FC101 and analogs as a method of treatment for cancer | Human Necessities | 2 | Expired |
| US9132280B2 | Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases | Human Necessities | 0 | Active |
| US8344020B2 | Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.